Biomarker Research for Personalized Medicine in Blood Cancer Patient
N/A
N/A
N/A
N/A
N/A
Open (Enrolling)
Both
Hematologic Neoplasms
Both
Hematologic Neoplasms
Trial Information
Biomarker Research for Personalized Medicine in Blood Cancer Patient
Inclusion Criteria:
- Korean
- Clinical diagnosis of Hematologic neoplasms
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Authority:
Korea: Institutional Review Board
Study ID:
09-029
NCT ID:
NCT01488591
Start Date:
April 2009
Completion Date:
Related Keywords:
- Hematologic Neoplasms
- Neoplasms
- Hematologic Neoplasms
Name | Location |
|---|
